Showing results (721-730 of 3,591) with videos related to
Sort By:
Pageof 360
Journal of Viral Hepatitis|March 12, 2014
Increased levels of IL-21 responses are associated with the severity of liver injury in patients with chronic active hepatitis BQ Pan, Y Yu, Z Tang, et al.Journal of Viral Hepatitis|January 16, 2008
Longitudinal changes in serum HBV DNA levels and predictors of progression during the natural course of HBeAg-negative chronic hepatitis B virus infectionG V Papatheodoridis, N Chrysanthos, E Hadziyannis, et al.Journal of Viral Hepatitis|January 16, 2008
Monocyte derived dendritic cells retain their functional capacity in patients following infection with hepatitis C virusE Barnes, M Salio, V Cerundolo, et al.Journal of Viral Hepatitis|January 29, 2008
Strategies for loading dendritic cells with hepatitis C NS5a antigen and inducing protective immunityH Yu, L A Babiuk, S van Drunen Littel-van den HurkJournal of Viral Hepatitis|January 29, 2008
Suppression of p38 mitogen-activated protein kinase inhibits hepatitis B virus replication in human hepatoma cell: the antiviral role of nitric oxideW-W Chang, I-J Su, W-T Chang, et al.Journal of Viral Hepatitis|January 29, 2008
Evaluation of initial virological response to adefovir and development of adefovir-resistant mutations in patients with chronic hepatitis BA Gallego, J Sheldon, J García-Samaniego, et al.Journal of Viral Hepatitis|January 29, 2008
In vitro effect of thymosin-alpha1 and interferon-alpha on Th1 and Th2 cytokine synthesis in patients with eAg-negative chronic hepatitis BE Loggi, A Gramenzi, M Margotti, et al.Journal of Viral Hepatitis|March 1, 2008
Economic impact of extended treatment with peginterferon alpha-2a and ribavirin for slow hepatitis C virologic respondersJ Nakamura, S-I Toyabe, Y Aoyagi, et al.Journal of Viral Hepatitis|March 1, 2008
Treatment of chronic delta hepatitis with lamivudine vs lamivudine + interferon vs interferonC Yurdaydin, H Bozkaya, F O Onder, et al.Journal of Viral Hepatitis|February 11, 2014
Acute and chronic immune biomarker changes during interferon/ribavirin treatment in HIV/HCV co-infected patientsM K Jain, B Adams-Huet, D Terekhova, et al.Pageof 360